With a robust background in venture capital, the fund manager has actively engaged in over 30 deals, primarily in the technology and healthcare sectors. Their investment strategy leans towards early-stage companies across North America and Europe, employing a data-driven approach to identify high-potential opportunities. Noteworthy exits include several successful acquisitions that have significantly enhanced portfolio returns. This operator-first methodology emphasizes deep collaboration with founders, fostering innovation and sustainable growth.